p53 disruption profoundly alters the response of human glioblastoma cells to DNA topoisomerase I inhibition
Authors:
- Shaojun ZhuSZShaojun Zhu
- Timothy F CloughesyTCTimothy F Cloughesy
- Linda M LiauLLLinda M Liau
- Paul S MischelPMPaul S Mischel
- 12 February 2004
- journal article
- Published by Springer Nature in Oncogene
- Vol. 23 (6) , 1283-1290
Abstract
A critical challenge in cancer research is to identify genetic lesions that sensitize patients to chemotherapy. p53, which is mutated in nearly one-third to half of glioblastomas, may be such a lesion. In this paper, we demonstrate that p53 disruption dramatically sensitizes glioblastoma cells to DNA topoisomerase I inhibitor-mediated apoptosis. Using 19 glioblastoma cell lines, including 15 low-passage ex vivo cell lines derived from patients, as well as isogenic glioblastoma cells varying in p53 status, we show that clinically relevant levels of SN-38 potently induce cell cycle arrest and temporary senescence in glioblastoma cells with wild-type p53 while causing massive apoptosis in p53-deficient cells (P<0.0002). We demonstrate that glioblastoma cells with wild-type p53 proliferate when recultured in drug-free medium, whereas p53-deficient cells do not. We also show that p16 protein expression is neither necessary nor sufficient for initiation and/or maintenance of SN-38-induced arrest/senescence. These results indicate that p53 disruption has a dramatic effect on how glioblastoma cells process topoisomerase I inhibitor-mediated DNA damage.Keywords
This publication has 38 references indexed in Scilit:
- c-Jun N-terminal Kinase Contributes to Apoptotic Synergy Induced by Tumor Necrosis Factor-related Apoptosis-inducing Ligand plus DNA Damage in Chemoresistant, p53 Inactive Mesothelioma CellsJournal of Biological Chemistry, 2003
- Identification of molecular subtypes of glioblastoma by gene expression profilingOncogene, 2003
- AcknowledgementDrugs, 2003
- Human Papilloma Virus 16 E6 Oncoprotein Inhibits Retinoic X Receptor-mediated Transactivation by Targeting Human ADA3 CoactivatorJournal of Biological Chemistry, 2002
- Cellular effects of CPT‐11 on colon carcinoma cells: Dependence on p53 and hMLH1 statusInternational Journal of Cancer, 2002
- Activation of a p53-independent, Sphingolipid-mediated Cytolytic Pathway in p53-negative Mouse Fibroblast Cells Treated with N-Methyl-N-nitro-N-nitrosoguanidineJournal of Biological Chemistry, 2001
- Activation of the Fas pathway independently of Fas ligand during apoptosis induced by camptothecin in p53 mutant human colon carcinoma cellsOncogene, 2001
- Unbound states by analytic continuation in the coupling constantPhysical Review C, 1999
- Primary and secondary glioblastomas: From concept to clinical diagnosisNeuro-Oncology, 1999
- The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53Cell, 1993